Cargando…
Semaphorins as emerging clinical biomarkers and therapeutic targets in cancer
Semaphorins are a large family of developmental regulatory signals, characterized by aberrant expression in human cancers. These molecules crucially control cell-cell communication, cell migration, invasion and metastasis, tumor angiogenesis, inflammatory and anti-cancer immune responses. Semaphorin...
Autores principales: | Mastrantonio, Roberta, You, Hua, Tamagnone, Luca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847692/ https://www.ncbi.nlm.nih.gov/pubmed/33537086 http://dx.doi.org/10.7150/thno.54023 |
Ejemplares similares
-
Semaphorin Signaling in Cancer-Associated Inflammation
por: Franzolin, Giulia, et al.
Publicado: (2019) -
Semaphorins and Their Receptors in Hematological Malignancies
por: Wei, Li, et al.
Publicado: (2019) -
Bad vessels beware! Semaphorins will sort you out!
por: Serini, Guido, et al.
Publicado: (2015) -
Semaphorins as Potential Immune Therapeutic Targets for Cancer
por: Jiang, Jun, et al.
Publicado: (2022) -
Semaphorins and their receptors in pancreatic cancer: Mechanisms and therapeutic opportunities
por: Liu, Dahai, et al.
Publicado: (2023)